Sutro Biopharma, Inc. (STRO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 98.32M |
| Enterprise Value | 55.86M |
| P/E Ratio | -0.1 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 3.07 |
| Price/Book Ratio | -0.06 |
| Enterprise/Revenue | 2.46 |
| Enterprise/EBITDA | -2.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.54 |
| Operating Margin | -1.16 |
| Return On Assets | -0.63 |
| Return On Equity | 1.93 |
| Revenue | 102.48M |
| Revenue/Share | 761.4 |
| Gross Profit | 95.16M |
| EBITDA | -145.65M |
| Net Income | -191.09M |
| Diluted EPS | -22.49 |
| Total Cash | 202.56M |
| Total Cash/Share | 1,548.34 |
| Total Debt | 13.63M |
| Total Debt/Equity | -0.2 |
| Current Ratio | 3.12 |
| Book Value Per Share | -511.28 |
| 52-Week Change | 294.87 |
| 52-Week High | 43.85 |
| 52-Week Low | 6.7 |
| Moving Average 50 Days | 31.81 |
| Moving Average 200 Days | 18.04 |
| Average Volume | 275,095 |
| Shares Outstanding | 9.68M |
| % Held by Institutions | 164.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | December 03, 2025 |